Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-09-000137
Filing Date
2009-02-11
Accepted
2009-02-11 15:04:36
Documents
1
Group Members
ASPEN ADVISORS LLCNIKOS HECHTSOPRIS CAPITAL ADVISORS, LLCSOPRIS CAPITAL, LLCSOPRIS PARTNERS SERIES A

Document Format Files

Seq Description Document Type Size
1 SC 13G/A arca_13ga2.txt SC 13G/A 25192
  Complete submission text file 0001019056-09-000137.txt   27597
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 09589416
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 152 WEST 57TH STREET FLOOR 39 NEW YORK NY 10019
Business Address 314 SOUTH GALENA STREET SUITE 300 ASPEN CO 81611 212-698-8006
Sopris Capital Advisors LLC (Filed by) CIK: 0001386790 (see all company filings)

EIN.: 203177754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A